Ajanta Pharma LimitedNSE: AJANTPHARM

Press Release Aug 30 2023

· Issued by Ajanta Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-30-2023-1

Ajanta Pharma Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Ajanta receives final approval from US FDA forTopiramate Extended Release Capsules".

View Attachment

6ix hasn’t read this filing yet.

Ajanta Pharma Limited on 6ix

Earlier from Ajanta Pharma

Later from Ajanta Pharma

All Ajanta Pharma news releases